Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | APR003 |
| Synonyms | |
| Therapy Description |
APR003 is an agonist of TLR7 that may promote cytokine production and activate anti-tumor immune response (Cancer Res 2020;80(16 Suppl):Abstract nr 684). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| APR003 | APR 003|APR-003 | TLR7 Agonist 13 | APR003 is an agonist of TLR7 that may promote cytokine production and activate anti-tumor immune response (Cancer Res 2020;80(16 Suppl):Abstract nr 684). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT04645797 | Phase I | APR003 | A Dose Escalation Study of APR003 in Patients With Advanced Colorectal Cancer (CRC) With Malignant Liver Lesions | Terminated | USA | 0 |